SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alexandre F. Trindade, Raquel F. M. Frade, Ermelinda M. S. Maçôas, Cátia Graça, Catarina A. B. Rodrigues, José M. G. Martinho, Carlos A. M. Afonso, “Click and go”: simple and fast folic acid conjugation, Organic & Biomolecular Chemistry, 2014, 12, 20, 3181

    CrossRef

  2. 2
    Christian Bailly, Cell-targeted cytotoxics: a new generation of cytotoxic agents for cancer treatment, Phytochemistry Reviews, 2014, 13, 1, 171

    CrossRef

  3. 3
    Christopher P. Leamon, Iontcho R. Vlahov, Joseph A. Reddy, Marilynn Vetzel, Hari Krishna R. Santhapuram, Fei You, Alicia Bloomfield, Ryan Dorton, Melissa Nelson, Paul Kleindl, Jeremy F. Vaughn, Elaine Westrick, Folate–Vinca Alkaloid Conjugates for Cancer Therapy: A Structure–Activity Relationship, Bioconjugate Chemistry, 2014, 25, 3, 560

    CrossRef

  4. 4
    R. T. Morris, R. N. Joyrich, R. W. Naumann, N. P. Shah, A. H. Maurer, H. W. Strauss, J. M. Uszler, J. T. Symanowski, P. R. Ellis, W. A. Harb, Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide), Annals of Oncology, 2014, 25, 4, 852

    CrossRef

  5. 5
    Allison J Ambrosio, Daphne Suzin, Edwin L Palmer, Richard T Penson, Vintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer, Expert Review of Clinical Pharmacology, 2014, 7, 4, 443

    CrossRef

  6. 6
    Paola B. Arimondo, Nicolas Guilbaud, Christian Bailly, Cancer Drug Design and Discovery, 2014,

    CrossRef

  7. 7
    Changli Du, Dawei Deng, Lingling Shan, Shunan Wan, Jie Cao, Junmei Tian, Samuel Achilefu, Yueqing Gu, A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery, Biomaterials, 2013, 34, 12, 3087

    CrossRef

  8. 8
    Anna Y. Kornilova, Bethany Algayer, Michael Breslin, George H. Addona, Victor Uebele, Development of a fluorescence polarization binding assay for folate receptor, Analytical Biochemistry, 2013, 432, 2, 59

    CrossRef

  9. 9
    Lindsay E. Kelderhouse, Venkatesh Chelvam, Charity Wayua, Sakkarapalayam Mahalingam, Scott Poh, Sumith A. Kularatne, Philip S. Low, Development of Tumor-Targeted Near Infrared Probes for Fluorescence Guided Surgery, Bioconjugate Chemistry, 2013, 24, 6, 1075

    CrossRef

  10. 10
    Nikolaus Krall, Jörg Scheuermann, Dario Neri, Entwicklung zielgerichteter niedermolekularer zytotoxischer Wirkstoffverbindungen mit DNA-codierten chemischen Bibliotheken, Angewandte Chemie, 2013, 125, 5
  11. 11
    Ayaka Okamatsu, Keiichi Motoyama, Risako Onodera, Taishi Higashi, Takahiro Koshigoe, Yasutaka Shimada, Kenjiro Hattori, Tomoko Takeuchi, Hidetoshi Arima, Folate-Appended β-Cyclodextrin as a Promising Tumor Targeting Carrier for Antitumor Drugsin Vitroandin Vivo, Bioconjugate Chemistry, 2013, 24, 4, 724

    CrossRef

  12. 12
    Feng Zhao, Hui Yin, Zhongxing Zhang, Jun Li, Folic Acid Modified Cationic γ-Cyclodextrin-oligoethylenimine Star Polymer with Bioreducible Disulfide Linker for Efficient Targeted Gene Delivery, Biomacromolecules, 2013, 14, 2, 476

    CrossRef

  13. 13
    Nikolaus Krall, Jörg Scheuermann, Dario Neri, Small Targeted Cytotoxics: Current State and Promises from DNA-Encoded Chemical Libraries, Angewandte Chemie International Edition, 2013, 52, 5
  14. 14
    Xuhua Liang, Yang Sun, Wenyuan Zeng, Lusha Liu, Xuan Ma, Yingyong Zhao, Jun Fan, Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate, Bioorganic & Medicinal Chemistry, 2013, 21, 1, 178

    CrossRef

  15. 15
    Jun J. Yang, Sumith A. Kularatne, Xianming Chen, Philip S. Low, Exing Wang, Characterization of in Vivo Disulfide-Reduction Mediated Drug Release in Mouse Kidneys, Molecular Pharmaceutics, 2012, 9, 2, 310

    CrossRef

  16. 16
    Khalid Abu Ajaj, Naser El-Abadla, Pia Welker, Samar Azab, Reiner Zeisig, Iduna Fichtner, Felix Kratz, Comparative evaluation of the biological properties of reducible and acid-sensitive folate prodrugs of a highly potent doxorubicin derivative, European Journal of Cancer, 2012, 48, 13, 2054

    CrossRef

  17. 17
    Pamela Pribble, Martin J Edelman, EC145 : a novel targeted agent for adenocarcinoma of the lung, Expert Opinion on Investigational Drugs, 2012, 21, 5, 755

    CrossRef

  18. 18
    Iontcho R. Vlahov, Christopher P. Leamon, Engineering Folate–Drug Conjugates to Target Cancer: From Chemistry to Clinic, Bioconjugate Chemistry, 2012, 23, 7, 1357

    CrossRef

  19. 19
    Karel Petrak, Targeted Drug Delivery––Quo Vadis?, Drug Development Research, 2012, 73, 2
  20. 20
    Dennis J. Yoon, Christina T. Liu, Devin S. Quinlan, Parsa M. Nafisi, Daniel T. Kamei, Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for Cancer, Annals of Biomedical Engineering, 2011, 39, 4, 1235

    CrossRef

  21. 21
    Soong-Hoon Kim, Nuria de Mas, Luca Parlanti, Olav K. Lyngberg, Guido Ströhlein, Zhenrong Guo, Konstantinos Dambalas, Victor W. Rosso, Bing-Shiou Yang, Kevin P. Girard, Zerene A. Manaloto, Germano D’Arasmo, Riccardo E. Frigerio, Wei Wang, Xujin Lu, Mark S. Bolgar, Madhushree Gokhale, Ajit B. Thakur, Synthesis, Chromatographic Purification, and Isolation of Epothilone–Folic Acid Conjugate BMS-753493, Organic Process Research & Development, 2011, 15, 4, 797

    CrossRef

  22. 22
    Jing Li, Edward A. Sausville, Patrick J. Klein, David Morgenstern, Christopher P. Leamon, Richard A. Messmann, Patricia LoRusso, Clinical Pharmacokinetics and Exposure-Toxicity Relationship of a Folate-Vinca Alkaloid Conjugate EC145 in Cancer Patients, The Journal of Clinical Pharmacology, 2009, 49, 12
  23. 23
    Philip Stewart Low, Sumith Anurasiri Kularatne, Folate-targeted therapeutic and imaging agents for cancer, Current Opinion in Chemical Biology, 2009, 13, 3, 256

    CrossRef

  24. 24
    Christopher P. Leamon, Fei You, Hari Krishna Santhapuram, Mingjin Fan, Iontcho R. Vlahov, Properties Influencing the Relative Binding Affinity of Pteroate Derivatives and Drug Conjugates Thereof to the Folate Receptor, Pharmaceutical Research, 2009, 26, 6, 1315

    CrossRef

  25. 25
    Kimberly R. Kalli, Ann L. Oberg, Gary L. Keeney, Teresa J.H. Christianson, Philip S. Low, Keith L. Knutson, Lynn C. Hartmann, Folate receptor alpha as a tumor target in epithelial ovarian cancer, Gynecologic Oncology, 2008, 108, 3, 619

    CrossRef

  26. 26
    Christopher P. Leamon, Ann L. Jackman, Folic Acid and Folates, 2008,

    CrossRef